https://www.selleckchem.com/pr....oducts/dir-cy7-dic18
001). During the same period, the incidence of aSAD combined with RCR remained relatively stable, from 51.7 to 45.8 per 100,000 (11.5% decrease) (P= .27). The overall incidence of oSAD declined from 7.1 to 2.2 per 100,000 (68.1% decrease) (P .001). The overall rate of aSAD has declined in recent years, primarily due to a large decrease in the incidence of aSAD without RCR as an isolated treatment for rotator cuff disorders. Prior studies have demonstrated a rising incidence of SAD; however, high-level clinical evidence and cl